Moneycontrol

Moneycontrol PRO

you are here: HomeNewsBusinessStocksBuy Ranbaxy Labs, target of Rs 620-630: Vivek Kumar

SHOW NAMES

Trending Topics

business

Buy Ranbaxy Labs, target of Rs 620-630: Vivek Kumar

Vivek Kumar, SBI Cap Securities advice traders to buy Ranbaxy Labs for target of Rs 620-630.

first published: Nov 8, 2012 06:43 pm

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Live: Nifty extends gain for the third day, up nearly 2% this week | Closing Bell | 4K
From renewables to AI and SMEs: Madhusudan Kela on where he senses opportunity now
Will The Pre-Diwali Nifty Rally Rage On Amid Weak Global Cues? RIL Q2 in Focus | Opening Bell Live
Infosys Q2 Earnings Live | Decoding Infosys Q2 Earnings | Earnings Express

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347